Join Now

Author Archives: Natalie Themm

Nelson Labs Celebrates 40 Years of Excellence in Science and Service

Nelson Labs Celebrates 40 Years of Excellence in Science and Service

Posted in BioUtah News | Tagged | Comments Off on Nelson Labs Celebrates 40 Years of Excellence in Science and Service

G2G Consulting Provides Updates from Washington D.C.

G2G Consulting Provides Updates from Washington D.C.

Posted in BioUtah News | Tagged | Comments Off on G2G Consulting Provides Updates from Washington D.C.

bioMérieux Recognized as Top 1% by S&P Global

bioMérieux Recognized as Top 1% by S&P Global

Posted in BioUtah News | Tagged | Comments Off on bioMérieux Recognized as Top 1% by S&P Global

Merit Medical Releases 12-Month Efficacy Results of the WRAPSODY® Cell-Impermeable Endoprosthesis (CIE)

Merit Medical Releases 12-Month Efficacy Results of the WRAPSODY® Cell-Impermeable Endoprosthesis (CIE)

Posted in BioUtah News | Tagged | Comments Off on Merit Medical Releases 12-Month Efficacy Results of the WRAPSODY® Cell-Impermeable Endoprosthesis (CIE)

E&I Ski Day 2025 Recap

E&I Ski Day 2025 Recap

Posted in BioUtah News | Comments Off on E&I Ski Day 2025 Recap

Merit Medical Rings Nasdaq Opening Bell to Celebrate 35-Year Partnership

Merit Medical Rings Nasdaq Opening Bell to Celebrate 35-Year Partnership

Posted in BioUtah News | Tagged | Comments Off on Merit Medical Rings Nasdaq Opening Bell to Celebrate 35-Year Partnership

The 2025 Wilson Sonsini E&I Summit Attracts Over 400 Participants

The 2025 Wilson Sonsini E&I Summit Attracts Over 400 Participants

Posted in BioUtah News | Comments Off on The 2025 Wilson Sonsini E&I Summit Attracts Over 400 Participants

First Patient Enrolled in Merit Medical’s PREEMIE Study

Multicenter, prospective study designed to evaluate safety and efficacy of Bloom™ Micro Occluder System for treatment of patent ductus arteriosus in premature infants

Posted in BioUtah News | Tagged | Comments Off on First Patient Enrolled in Merit Medical’s PREEMIE Study

iVeena Secures $3 Million in Series B-2 Financing to Accelerate Development of IVMED-85 for Myopia

iVeena Secures $3 Million in Series B-2 Financing to Accelerate Development of IVMED-85 for Myopia

Posted in BioUtah News | Tagged | Comments Off on iVeena Secures $3 Million in Series B-2 Financing to Accelerate Development of IVMED-85 for Myopia

Altitude Lab Demo Day

As part of BioHive week, Altitude Lab hosted its annual Demo Day.

Posted in BioUtah News | Tagged | Comments Off on Altitude Lab Demo Day

Steve Pacelli Appointed CEO of Epitel, Inc.

Pacelli, A Former Executive of Dexcom, Inc., Will Lead Epitel Into Its Next Phase of Growth

Posted in BioUtah News | Tagged | Comments Off on Steve Pacelli Appointed CEO of Epitel, Inc.

Sera Prognostics Announces Pricing of $50 Million Public Offering

Sera Prognostics Announces Pricing of $50 Million Public Offering

Posted in BioUtah News | Tagged | Comments Off on Sera Prognostics Announces Pricing of $50 Million Public Offering